Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China · Delayed Price · Currency is CNY

4.880

+0.050 (1.04%)

Aug 4, 2026, 3:04 PM CST

SHE:300318 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	812.78	824.58	851.69	1,045	795.93	714.75
Revenue Growth	2.71%	-3.18%	-18.53%	31.35%	11.36%	-3.25%
Gross Profit	273.74	293.87	417.53	451.46	253.51	292.47
Operating Income	-41.87	-33.51	62.86	58.97	-99.16	-111.98
Net Income	-95.15	-91.92	9.25	-24.93	-78.44	-322.18
Earnings Per Share	-0.12	-0.11	0.01	-0.03	-0.10	-0.39
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Inspection and Testing Division	238.15
Biological Products	586.43
Total	824.58

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	142.52	121.83	77.26	104.93	113.6	39.39
Total Debt	927.24	1,125	1,051	807.04	787.99	552.68
Net Cash (Debt)	-784.71	-1,003	-973.95	-702.11	-674.39	-513.29
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.96	-1.23	-1.19	-0.86	-0.83	-0.63

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-143.87	-135.17	-38.69	137.02	40.72	0.89
Capital Expenditures	-151.1	-156.92	-188.95	-197.54	-161.46	-367.06
Free Cash Flow	-294.97	-292.09	-227.64	-60.53	-120.74	-366.17
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	33.68%	35.64%	49.02%	43.18%	31.85%	40.92%
Operating Margin	-5.15%	-4.06%	7.38%	5.64%	-12.46%	-15.67%
Pretax Margin	-22.13%	-20.78%	2.34%	3.23%	-16.81%	-70.54%
Profit Margin	-11.71%	-11.15%	1.09%	-2.38%	-9.86%	-45.08%
FCF Margin	-36.29%	-35.42%	-26.73%	-5.79%	-15.17%	-51.23%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	505.37	-	-	-
Forward PE	-	61.83	61.83	61.83	61.83	61.83
PS Ratio	4.90	6.21	5.49	4.88	6.00	11.33